Enolen is currently being studied in a Phase 1 trial evaluating its safety, tolerability and preliminary efficacy for localized sustained delivery of enzalutamide into the prostate. Alessa expects to ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

BUFFALO, N.Y. – Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical ...

Emerging evidence suggests that fasting could play a role in the fight against cancer. However, studies to date have been relatively small and results have been mixed, leaving an unclear picture of ...

HLD-0915 has received FDA fast track designation for mCRPC, expediting its development and review process to address unmet medical needs. Halda Therapeutics is conducting a phase 1/2 clinical trial to ...

When it comes to men’s health, prostate cancer tends to fly under the radar—until it doesn’t. Prostate cancer is one of the most common cancers in American men, second only to skin cancer. And yet, ...

Smoking Linked to Higher Prostate Cancer Mortality Men who smoke at the time of their prostate cancer diagnosis have an increased risk for all-cause, cardiovascular, and prostate-cancer-specific death ...

Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment which means the medicines will travel ...

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of side effects, a study suggests. Using AI, scientists found that images ...

If your cancer is not causing any symptoms, is growing slowly, or is small and only in your prostate, your physician may suggest active surveillance or watchful waiting instead of treatment. Active ...